Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

Data Sources

Data sources we collected to analyse this study.

Full Text
PDF
Crossref
PubMed
Classification
Summary
Quality Score
Content

Publication

Journal

Diabetes

Year

2017

Authors

C. B. Guzman, Xiaotian M Zhang, Rong Liu, A. Regev, S. Shankar, P. Garhyan, S. Pillai, C. Kazda, N. Chalasani, T. Hardy

Open Access
145 citations